📰 Dapto News
Page 94 - Dapto News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Dapto. Real-time updates on events, politics, business and more.
March 30, 2023
INTERACTIVE: Search for the booth you voted at and see how first preferences fell in your suburb.
March 30, 2023
A number of research firms have changed their ratings and price targets for Aptose Biosciences (NASDAQ: APTO): 3/27/2023 – Aptose Biosciences had its price target lowered by analysts at Canaccord Genuity Group Inc. from $13.00 to $8.00. They now have a “buy” rating on the stock. 3/25/2023 – Aptose Biosciences is now covered by analysts […]
March 29, 2023
"A lot of vulnerable people use it as a coping strategy for issues they've got in life."
March 29, 2023
"A lot of vulnerable people use it as a coping strategy for issues they've got in life."
March 29, 2023
Wests also beat Meadow in round one action.
March 29, 2023
"A lot of vulnerable people use it as a coping strategy for issues they've got in life."
March 29, 2023
"A lot of vulnerable people use it as a coping strategy for issues they've got in life."
March 29, 2023
Lee Stinson clinched back-to-back Zone 16 State Singles titles with an epic 25-24 victory over an unlucky John...
March 29, 2023
"Keeping emergency departments for emergencies is really important for the whole community, because they deal with a vast...
March 29, 2023
StockNews.com assumed coverage on shares of Aptose Biosciences (NASDAQ:APTO – Get Rating) (TSE:APS) in a research report released on Saturday morning. The brokerage issued a hold rating on the biotechnology company’s stock. Separately, Royal Bank of Canada reiterated an outperform rating and issued a $5.00 price objective on shares of Aptose Biosciences in a research […]